In addition, Krzeslak et al. (32) reported that GLUT-1 expression was observed in 50% of breast carcinoma patients and that GLUT-1 expression was detected at a higher rate in poorly differentiated tumors than well-differentiated tumors. Here, SLC2A1 is linked to breast carcinoma.